Investigational Medicinal Product (IMP)
Also: IMP
A pharmaceutical form of an active substance or placebo being tested, or used as a reference, in a clinical trial.
IMP moves under the clinical trial authorisation rather than a marketing authorisation, and its movement must be accountable from receipt through dispensing to return or destruction.
IMP import into the EU or UK requires an MIA(IMP) and QP certification.